MY176503A - Hypoglycemic effect enhancer - Google Patents

Hypoglycemic effect enhancer

Info

Publication number
MY176503A
MY176503A MYPI2011004557A MYPI2011004557A MY176503A MY 176503 A MY176503 A MY 176503A MY PI2011004557 A MYPI2011004557 A MY PI2011004557A MY PI2011004557 A MYPI2011004557 A MY PI2011004557A MY 176503 A MY176503 A MY 176503A
Authority
MY
Malaysia
Prior art keywords
hypoglycemic effect
effect enhancer
bacteria
enhancer
acid bacteria
Prior art date
Application number
MYPI2011004557A
Other languages
English (en)
Inventor
Yasuhiro Isa
Shimakawa Masaki
Ohno Hiroshi
Hideki Yamamura
Original Assignee
Biofermin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofermin Pharmaceutical Co Ltd filed Critical Biofermin Pharmaceutical Co Ltd
Publication of MY176503A publication Critical patent/MY176503A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/225—Faecalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/517—Bifidum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2011004557A 2009-03-26 2010-03-25 Hypoglycemic effect enhancer MY176503A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009077555 2009-03-26

Publications (1)

Publication Number Publication Date
MY176503A true MY176503A (en) 2020-08-12

Family

ID=42781065

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2011004557A MY176503A (en) 2009-03-26 2010-03-25 Hypoglycemic effect enhancer

Country Status (5)

Country Link
US (1) US8889375B2 (OSRAM)
JP (2) JP5536504B2 (OSRAM)
MY (1) MY176503A (OSRAM)
SG (2) SG174540A1 (OSRAM)
WO (1) WO2010110374A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012011174A1 (ja) * 2010-07-22 2012-01-26 ビオフェルミン製薬株式会社 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
JP6983407B2 (ja) * 2015-07-07 2021-12-17 東亜薬品工業株式会社 菌含有口腔内速崩壊性錠剤
KR101697260B1 (ko) * 2015-07-27 2017-01-17 고려대학교 산학협력단 보글리보즈를 유효성분으로 함유하는 비만 개선, 정장 또는 장내 균총 개선용 조성물
JP6637725B2 (ja) * 2015-10-28 2020-01-29 ビオフェルミン製薬株式会社 ウイルス感染症の予防及び／又は治療剤
JP6718512B2 (ja) 2016-09-02 2020-07-08 富士フイルム株式会社 家畜用飼料又は家畜用サプリメント、ラクトバチルス属細菌の増殖促進剤、並びにラクトバチルス属細菌の増殖促進方法
JP7235270B2 (ja) * 2018-02-09 2023-03-08 エースバイオプロダクト株式会社 血糖値上昇抑制剤及び同血糖値上昇抑制剤の製造方法
WO2020142698A1 (en) * 2019-01-05 2020-07-09 Foremost Technologies and Products, Inc. High pressure processing of foods and supplements
CN111748000B (zh) * 2019-03-29 2022-05-20 沈阳药科大学 3-脱氧-5-羟基-1-氨基碳糖类化合物及其用途
JP2020184909A (ja) * 2019-05-13 2020-11-19 学校法人帝京大学 血糖降下剤、及び、該血糖降下剤を含有する飲食品
CN112386612A (zh) * 2020-12-01 2021-02-23 贾卫国 一种用于预防糖尿病的益生菌生物制剂及其制备工艺
US20240174619A1 (en) * 2021-03-03 2024-05-30 Emergent Product Development Gaithersburg Inc. Valiolamine derivatives as glucosidase inhibitors
CN118620807B (zh) * 2024-08-15 2024-10-22 山东健源生物科技有限公司 一株具有减肥、降血糖作用的乳酸片球菌及其后生元和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194794A3 (en) 1985-03-08 1986-12-17 Takeda Chemical Industries, Ltd. Saccharide digestion inhibiting composition
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
JPH107577A (ja) 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
JP2004113068A (ja) * 2002-09-25 2004-04-15 Sanwa Kosan Kk 腸内ビフィズス菌増殖促進剤
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
JP2004357505A (ja) * 2003-05-30 2004-12-24 Fancl Corp 胃腸疾患予防・軽減のための犬用サプリメント
JP4463525B2 (ja) * 2003-10-23 2010-05-19 ビオフェルミン製薬株式会社 減感作療法用剤
JP2006020581A (ja) * 2004-07-08 2006-01-26 Cdom:Kk ペット用食品及びその製造方法
JP2006020606A (ja) 2004-07-09 2006-01-26 Someya Hideo 肥満防止、改善のための健康食品用組成物
JP2006055116A (ja) * 2004-08-23 2006-03-02 Michiyo Miura α−グルコシダーゼ活性阻害食品
CA2655665A1 (en) 2006-05-26 2007-12-06 Nestec S.A. Methods of use and nutritional compositions of touchi extract
JP2007330124A (ja) 2006-06-13 2007-12-27 Kenko Tsusho Kk 肥満及び生活習慣病の防止・改善をする為の健康食品用組成物
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Ｔｋバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬
JP2008222701A (ja) * 2007-03-09 2008-09-25 Kangwon National Univ Industry Cooperation Foundation 肥満予防及び治療用発酵物、糖尿病予防用発酵物、肥満予防及び治療用発酵食品および糖尿病予防用食品

Also Published As

Publication number Publication date
JP5536504B2 (ja) 2014-07-02
JP5932878B2 (ja) 2016-06-08
US8889375B2 (en) 2014-11-18
US20120014923A1 (en) 2012-01-19
WO2010110374A1 (ja) 2010-09-30
JP2014141526A (ja) 2014-08-07
SG174540A1 (en) 2011-10-28
SG10201400931RA (en) 2014-07-30
JP2010248185A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
MY176503A (en) Hypoglycemic effect enhancer
WO2011113798A3 (en) Inhibitors of semicarabazide - sensitive amine oxidase
WO2008127275A3 (en) Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
MX2010002974A (es) Formas solidas de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4- dihidro-4-oxoquinolin-3-carboxamida.
WO2011006126A3 (en) Engineered microorganisms with enhanced fermentation activity
EP4285909A3 (en) Use of hsp70 as a regulator of enzymatic activity
MX2009004724A (es) Composicion para reducir micotoxinas.
MX356086B (es) Produccion de acidos grasos y derivados de los mismos.
AP2011005639A0 (en) Fermentation process starting from cellulosic biomass and involving the recirculation of detoxified stillage into the process.
EA201190008A1 (ru) Термофильные микроорганизмы не способные к спорообразованию для продукции этанола
PL2079308T3 (pl) Sposób zapobiegania rozwojowi mikroorganizmów oraz kombinacja do zapobiegania rozwojowi mikroorganizmów
NZ598704A (en) Hang tab and product tag assembly, and method of use
MY142488A (en) Tea-based fermentation beverage and tea beverage
UA106372C2 (en) Enzymatic complex
GEP20135800B (en) Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation
MX2012007873A (es) Promotor de reparacion del daño de acido desoxirribonucleico para aplicacion oral e inhibidor de la actividad de elastasa para apalicacion oral.
PH12013501293A1 (en) Use of nitrogen-free peroxygen-releasing compound to reduce growth of contaminant microorganisms in ethanol fermentation
EA200970226A1 (ru) Термофильные микроорганизмы для производства этанола
MY152388A (en) Composition and method for controlling plant diseases
WO2010080305A3 (en) Microbicidal compositions including activated nitrogenous compound and 1,4-bis (bromoacetoxy)-2-butene, and methods of using the same
BR112012022603A2 (pt) bactéria altamente produtiva produtora de álcool isopropyl
SG11201901504TA (en) Bacterial, fungal, and yeast growth inhibitor containing allulose
MX2009012929A (es) Compuestos organicos.
WO2011006097A3 (en) Methods For Treating Toxicity
PH12011000384A1 (en) Pesticidal composition and method for controlling pests